Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Breast Cancer
Interventions: DRUG: FS-1502
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.